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II. INTRODUCTION
Pyruvate oxidase (pyruvate:cytochrome bj oxldoreductase EC 1.2.11.2) Is a 
peripheral membrane enzyme of E. coll (1). The tetramerlc enzyme requires the 
noncovalent binding of one FAD and one TPP molecule per monomer for activity.
A divalent cation Is also needed for activity (2). Pyruvate oxidase catalyzes 
the oxidative decarboxylation of pyruvate to acetate, COg, and reduced FAD 
(1). Reduced FAD 1s oxidized In vivo by a cell membrane electron transport 
system that Includes ublqulnone- 6  and cytochrome bj (3,4). FAD can be 
oxidized In vitro by electron acceptors as ferrlcyanlde, which 1 s used 1 n this 
laboratory for routine assay purposes. The monomeric weight of the enzyme Is 
60,000 dal tons (S).
The activity of pyruvate oxidase can be Increased up to 25 fold by either 
mild pro olytlc treatment (6 ) or the binding of monomeric or micellar 
amphlphi 1 es (7). Proteolytic treatment leading to activation occurs when TPP, 
a divalent cation, and reduced FAD are present. Both the substrate pyruvate 
and the reducing agent dlthionite can reduce the FAD group (6 ). L1p1d 
activation 1s found when TPP, a divalent cation, arid pyruvate are present with 
the 11p1d. Pyruvate oxidase demonstrates an increased affinity for lipid 
binding under the same conditions as for 11p1d activation. Flavin reduction 
Is not necessary 'or Increased lipid binding (8 ), Proteolytic nicking and 
lipid binding have been shown to be mutually exclusive (9). This observation 
has led to the hypothesis that proteolytic and lipid activation Involve 
similar conformational changes.
This laboratory 1s involved 1n elucidating the molecular mechanism by 
which activation occurs. The purpose of my project was to determine the 
distance between the lipid binding site and the FAD cofactor. Such 
Information should help elucidate the lipid activation mechanism.
2Pyruvate oxidase contains both high and low affinity lipid binding 
sites. The high affinity sites are Involved In enzyme activation. The low 
affinity binding sites have been shown to number at least J.5 sites per 
tetramer (8 ). Pyruvate oxidase can be activated by both anionic and cationic 
amphlphlles. Since the of binding 1s lower for anionic lipids than for 
cationic lipids, 1t was hypothesized that a positively charged group Is near 
the high affinity I1p1d binding site. Using cerbodflmlde, John White has 
covalently bound laurlc acid to the high affinity binding sites. This 
technique has made 1t possible for a fluorescent fatty acid to be covalently 
bound to the enzyme. Covalently binding a fluorescent fatty add to the high 
affinity sites Is the first step In energy transfer experiments to determine 
the distance between the high affinity sites and the FAO cofactor.
Forster developed the theory or dipole-dipole energy transfer (10). 
Electronic excitation energy can be transferred from a fluorescent energy 
donor to an appropriate energy acceptor over distances as great at 70 A.
The distance between the centers of the donor and acceptor can be determined 
by measuring the efficiency of energy transfer (11). In the case of pyruvate 
oxidase, the donor would be a fluorescent fatty acid and the acceptor would be 
FAO or an appropriate analog (FMN, riboflavin).
3II. EXPERIMENTAL PROCEDURES
A. Materials
Beta-Par1nar1c acid (BPA), l2-(9-anthroyloxy)dodecano1c acid (ADA), and 
1-pyrenedodecanolc acid (PDA) were purchased from Molecular Probes, Inc. The 
company has moved across the country several times and Is presently located 1n 
Junction City, Oregon. AnlMnonaphthalenesulfonate (ANS) was a gift from G. 
Weber's laboratory. Sodium dodecyl sulfate (SOS) was purchased from Pierce. 
Argon was obtained from Air Products and dimethyl sulfoxide (DMSO) from E.K. 
Industries. 2,6-d1tert-butyi p-cresol (BHT), thiamin pyrophosphate (TPP), 
sodium pyruvate, and ovalbumin were bought from Sigma. Sodium ferrlcyanlde 
was purchased from ICN Pharmaceuticals.
B. Methods
1. Purification of Pyruvate Oxidase
I have purified the enzyme three times, the last time alone. The 
procedure 1s outlined In a paper by Recny and Hager (12). Several variations 
from the published protocol were used:
a) HPIC was used Instead of Sephadex G-200 chromatography for 
the last step.
b) Pyruvate oxidase was Isolated from F. coll CG-5 after 
January 1983 because the W191-6 strain previously used 
no longer contained active enzyme.
c) The final concentration of Polymln P added to the enzyme 
extract wav changed from 0.33* to 0.175*. The change was 
necessary because of the new strain used.
42. Enzyme Assays
The activity of pyruvate oxidase was assayed In 0.5 cm cuvettes at room 
temperature. The procedure was :
a) Mix 600 |il assay buffer
0 -2 0 pi pyruvate oxidase 
200 pi 100 pM SOS
b) Incubate six minutes
c) Add 200 pi 45 mM Na3Fe(CN) 6
d) Mix and record decrease of A 450  
The assay buffer contained:
180 pM TPP
226 mM Na pyruvate
16.4 mM MgCl2 x 6H20 
10.2 mM Na2HP04
72.5 mM NaH2P04 .H20 
pH adjusted to 6.0
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For assays using lipids other than SDS, 50 pi of the lipid In DMSO and 
150 pi of water were substituted for 200 pi of SDS solution. Specific 
activities were calculated by the formula:
Specific activity ■ 6 (change In A^g/10 sec)
(pmole C0,,m1n”*mg~*) (0.218) (ml of aliquot) (concentration of
sample 1 n mg/ml)
3. Protein Determinations
I have used four methods to quantitate protein 1n a sample. All values 
are for 1 . 0  cm cuvettes:
5a) Concentration (1n mg/ml) a 0.84 x A230
This method Is least accurate and was used only when 
the others didn't work or were not available.
b) Concentration (In mg/ml) a 1.45 x A280 ■ »74 x ^ 6 0  
This Is more accurate than the preceding method since 
this method accounts for nucleotide absorbance (13).
c) Concentration (in mg/ml) * 4.11 x A4 3 3
This method should only be used for purified, oxidized 
pyruvate oxidase since It depends on the extinction 
coefficient of pure, oxidized enzyme (2 ).
d) Bradford method (14) using Bio-Rad protein dye reagent.
This Is the preferred method because of Its accuracy and 
ability to measure protein for any redox and purity state 
of pyruvate oxidase. With each assay an ovalbumin standard 
composed of duplicates should be prepared. This accounts 
for color changes resulting from differences In Incubation 
time and temperature across assays.
4. Handling of Fluorescent Probes
The handling of beta-par1nar1c acid followed the techniques outlined by 
R. Fairley (15). The fatty acid was minimally exposed to air and all 
solutions containing the fatty acid were deaerated with argon for at least ten 
minutes. Deaeration procedures were not required for the handling of 
anthroyloxydodecanolc acid and pyrenedodecanolc acid. However, the solid 
samples were stored wrapped 1n foil, since they are light sensitive.
a5. CMC Determinations
The CMC of fatty acids was determined by light scattering at 660 nm. 
When the light scattering rose above negligible levels, micelles were being 
formed.
6 . Covalent Binding of Lipids to Pyruvate Oxidase 
The protocol of the covalent binding reaction and the subsequent dilution 
assay was:
Mix 385 pi 2X assay buffer
363 pi 50Y glycerol In water
1 1 1 pi 2 . 6  mg/ml pyruvate oxidase
50 U1 I1p1d activator In OMSO
910 pi
Incubate six minutes
c) Add 90 pi of 7.84Y (w/v) carbodllmlde
d) Remove 10 pi aliquot and add to:
600 pi assay buffer 
190 pi water
e) Immediately add 200 pi 45 mM ^FevCNjg
f) Record decline of A4 5 0
A carbodllmlde control should always be prepared with the experimental 
sample. The control contains the same reagents as the experimental sample but 
for carbodllmlde. 20 pi aliquots were removed Instead of 10 pi aliquots for 
the dilution assays with BPA and PDA. The covalent binding reaction often was 
run at a multiple of the values given. The final concentration of the enzyme 
1n the binding reaction varied from 0.2 mg/ml to 0.3 mg/ml. ROY
glycerol was added to give a final concentration of roughly 20% (v/v).
Glycerol helps stabilize the enzyme.
7. Spectral Measurements
A11 absorbance spectra and most enzyme assays were measured by a Cary 219 
spectrophotometer. Occasionally, a Beckman Cl 11 spectrophotometer was used 
for enzyme assays. Fluorescence spectra were recorded with G. Weber's 
fluorometer or the MPF-44 fluorcmeter In R. Gennls's laboratory.
8 . Attempts to Reoxidize Reduced, Lipid Bound Pyruvate Oxidase
Three techniques were tried to reoxidize Upld covalently bound pyruvate
oxidase:
a) Dialysis
A 1.5 ml sample of pyruvate oxidase covalently bound to ADA and a 1.5 ml 
carbodllmlde control were separately dlalzyed against 1.0 1 of 1Q0 mM NaP04 , 
20% glycerol, pH 6.0 buffer. After two hours, the samples were placed In
1.0 1 NaP04 buffer containing 45 mM K3 Fe(CN)g. After two hours 1n the second 
dialysis buffer, the samples were placed 1 n four successive changes over 12  
hours of the original buffer. The cycle was again repeated, but over 2.5 days 
Instead of 16 hours.
b) D1 thlonlte reduction and reoxidation with O2
Na dlthlonlte was added to pyruvate oxidase to reduce the enzyme. The 
covalent binding reaction mixture contained the appropriate amount of 2X assay 
buffer without pyruvate. After the covalent binding could have occurred, the 
sample could be bubbled with oaygen to oxidize Na dlthlonlte and the lipid 
bound enzyme. A11 samples but the enzyme and Na dlthlonlte solutions were 
deaerated with Argon.
8c) Chelation of Mn2+
Since Mn2+ Is not soluble In a NaPO^ solution, a 2X hepes buffer was used 
in Heu of the 2X assay buffer In the covalent binding reaction.
2X hepes buffer 
100 pM Mn2+
1.0 irM TPP 
200 rnM Na pyruvate 
200 mM hepes 
pH adjusted to 6 .8
After the carbodllmlde addition arid a six minute Incubation, 0.65 M EDTA 
1n water was added to the covalent binding reaction mixture to give a final 
concentration of 70 nfl. The chelator EDTA does not readily dissolve In 
water. Increasing the pH to 13, however, easily dissolves the EDTA. The pH 
can then be lowered to 8.2 while still maintaining EDTA 1n solution. The 
final concentration of the enzyme was 0 . 2  mg/ml In these experiments.
9. Attempts to Separate Covalently Bound and Unbound Probe
I have tried six techniques to separate covalently bound and unbound 
anthroyloxydodecanolc acid. The Hp1d:monomer ratio In all the samples 
containing covalently bound ADA was 2:1. The final enzyme concentration of 
the binding reaction was between 0.20 mg/ml and 0.32 mg/ml. The carbodllmlde 
control was treated exactly the same as the sample with covalently bound ADA.
a) Ammonium sulfate precipitation
To a 1 . 8  ml sample containing covalently bound ADA, I added ammonium 
sulfate to give 100X saturation. After centrifuging down the precipitated
9enzyme, the pellet was resuspended In 2.0 ml of 100 mM NaP04 , 20% glycerol, pH
6.0 buffer. After centrifuging to clarify the solution, the enzyme was again 
precipitated and resuspended. The temperature of the sample was always 4®C.
b) Dialysis
Three approaches to separate unbound AOA from bound ADA by dialysis were 
tried. The dialysis experiments were carried out using 12,000-14,000 
molecular weight cutoff, standard cellulose dialysis tubing from Spectrapor. 
Dialysis was performed at 4°C.
The first experiment Involved dialyzing a 4 ml covalent binding reaction 
mixture over two days against 1.0 1 of 100 mM NaP04 , 20% glycerol, pH 6.0 
buffer containing 5 x 10"3% (w/v) bovine serum albumin. The binding reaction 
mixture had a 38:1 ADA:monomer ratio. The dialysis buffer was changed once 
after the first day. After the second day, the fluorescence emission spectra 
of the samples excited at 361 nm were recorded.
The second experiment tested the movement of ADA through the dialysis 
tubing. 10 ml of 3.0 x 1 0 " 5 M ADA In 100 mM NaP04 , 20% glycerol, pH 6 .0  
buffer was dialyzed against 4.0 1 of the same NaP04 buffer for 100 hours. The 
dialysis buffer was changed after the second through sixth measurements of 
A3 5 7 * The buffer flask was; wrapped In foil to mlnlmze light exposure.
The third experiment was undertaken to determine whether reduced„ ADA 
covalently bound enzyme could be reox1d1zed, The protocol 1s given 1n chapter 
IIBt section 8a,
c) U1 traf1 1 trat1 on
Samples containing ADA covalently bound enzyme were concentrated by an 
Amlcon ultraflltrator, 100,000 MW cutoff» type c ultra-filtration membranes 
from Nucleopore were used (XM100), 50*000 MW cutoff membranes (XM50) were
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also used In the controls to test If the ADA was removed from the solution. 
Some samples were concentrated through more than one ultraflltratlon cycle.
For example, one sample was concentrated to half Its original volume and 
buffer was added to bring the solution up to the original volume. This was 
repeated three times so the total dilution and concentration was 8 fold. The 
buffer used 1n diluting the samples was either assay buffer or 100 mM NaP04, 
20% glycerol, pH 6.0 buffer.
d) Ion-retardation resin
A 1 x 15 cm column of AG11A8 from B1 o-Rad was prepared by swelling 6 g of 
the resin In 100 mM NaPO^, 20% glycerol, pH 6,0 (5.5 for the second run) 
buffer. The column was washed with approximately 5 volumes of 1.0 M NH4CI and 
then 20 volumes of the same NaP04 buffer 1 n which the resin was swelled.
After loading a sample, the column was washed with the column buffer and 1.5 
ml fractions were collected. The elution profile of the enzyme was monitored 
by A4 3g measurements, and the elution of ADA was followed by measuring the 
A3 6 7 of the fractions. Occasionally, the column was washed with a strong 
1on1c solution, as 1.0 M NaCl or 3.0 M NaCl, after the NaP04 washes, to 
attempt to elute enzyme or ADA tightly bound to the column. The column was 
run at room temperature.
e) Extraction with organic solvents
Two ml samples of pyruvate oxidase covalently linked with ADA were 
extracted with six ml of organic solvent. Extraction was attempted with 
chloroform and heptane. The extraction was performed at 4°C In foil wrapped 
vials. All the samples were stirred slowly and simultaneously since a 4 place 
stir plate was used. After eight hours of gentle stirring the stir rate was
11
Increased. After seven hours at an Increased stir rate I shook the samples
vigorously by hand 1 n series of four shakes,
f) Sephadex G-50 column
Two columns were used. The first measured 1 x 10 cm and the second 1.4 x 
24 cm. All manipulations except for swelling were done at 4°C. The resins 
were swelled at 90°C In water for one hour. The resins were then allowed to 
cool before pouring. After pouring, the column were washed with 2-5 volumes 
of 150 nW NaP0 4 , 25* glycerol, pH 6.0 buffer. The samples were eluted with 
the same buffer. The sample size was 0.5 ml for the smaller column and 2.0 ml 
for the larger column. The void volumes wt?re determined by Blue Dextran 2000 
to be 2 ml and 15 ml. The elution of the enzyme was followed by A4 3 8  
measurements and occasionally by the Bio-Rad protein assay. Elution of the 
assay buffer components was followed by A2gg and the elution of ADA by Agg; 
measurements.
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III. RESULTS
A. Purification of Pyruvate Oxidase
Tha new C6-5 strain contains more than three times the total pyruvate 
oxidase activity than the old W191-6 strain:
Strain
Act1v1ty/dry weight of cells 
(nmole C0? evolved m1n"Vfl)
W191-6 33.5 (from reference 12)
C6-5 118. (from cells grown by 
G. Lelsman and R. Lenhardt)
The results of my enzyme preparation using the new bacterial strain are 
given In table 1 and figure 1. The HPLC purification step was not used In 
this preparation because the enzyme was sufficiently pure. This Is seen In 
the SDS polyacrylamide gel of the purification fractions In figure 1. The 
enzyme can be stored at 3-4 mg/ml In 100 mM NaPO/j, 20% glycerol, pH 6.0 buffer 
at 4°C and be stable for months. At high concentrations, 10-15 mg/ml, and 
under the same conditions, the enzyme concentration falls to half the original 
1 n a few weeks with little change In specific activity.
B. Probe Activation of Pyruvate Oxidase
The activation profiles of four fluorescent probes are shown 1n figures 2 
and 3. The four probes, beta-parlnarlc acid, anilInonaphthalenesulfonlc acid, 
anthroyloxydodecanolc acid, and pyrenedodecanolc acid all activate pyruvate 
oxidase substantially more than the water and OMSO controls. The water 
control measures the activity of unactivated pyruvate oxidase. The OMSO 
control measures how much the solvent carrier of the probes, OMSO, activates 
the enzyme.
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Table 1
Purification of Pyruvate Oxidase from the New CG-5 Strain
Purification step
Total
protein
. img)
Total
activity . 
(umole CO^In'1)
Specific 
activity .
(umole COjf/Kln"1mg_1) %  Recovery
1 . Crude extract 60,200 8 8 ,0 0 0 1.46 100
2 . Polymln P 
supernate
42,200 81,200 1.92 92.2
3e Ammonium sul fate 
fractionation
19,700 46,700 2.36 53.1
4. Heat denaturatlon 3,660 39,400 10.7 44.8
5. Concentrated OEAE 
Sephadex fractions
188 17,800 94.6 2 0 . 2
6 . Low Ionic strength 
precipitation
6 8 .2 7,670 1 1 2 8.7
Figure 1
SDS Polyacrylamide Gel of Purification Steps
Step (see figure 1) 
1
BSA and ovalbumin 
'"standards
pv; in
%% '/’ i f f  s b $  4cf>^i‘/tf
mi" ‘ K lH ftffl ffrtTTRTfn i > ff h  ! n m »  miTTt rrmrni r; rnmn m : n im i ; r ? nm
P  S,.
<ea»
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Since DMSO was the probe solvent, I examined the effects of DHSO on 
unactivated and 11p1d (SDS) activated enzyme. The results shown 1n figures 4A 
and 4B demonstrate that DNSO activates unactivated enzyme and Inactivates 
Hpld activated enzyme.
C. Covalent Binding of L1p1ds to Pyruvate Oxidase 
The covalent binding reaction with carbodllmlde and the subsequent 
dilution assay to prove covalent binding were tried with four different 
lipids:
1. Beta-par1nar1c add and 1 auric acid 
I tried seven times to covalently bind beta-parlnarlc acid to pyruvate 
oxidase. The results of the dilution assays of the attempts are summarized In 
Table 2. It appears as beta-par1nar1c acid was not covalently bound to the 
enzyme. To test for faulty reagents or technique, I tried and succeeded In 
covalently binding laurlc acid to the enzyme. Good evidence for covalent 
binding occurs when the experimental sample's activity 1$ 200X that of the 
carbodllmlde control's activity. Typical dilution assay time courses for BPA 
and laurlc acid are shown 1n figures 5A and SB. In the last attempt to 
covalently bind beta-parlnarlc acid to the enzyme, I pre-reacted BPA with 
carbodllmlde before adding the lipid to reduced enzyme. The BHT concentration 
In the BPA In DMSO stock solutions was kept at .02* (w/v), ten times less than 
what 1s used 1n the literature. The concentration was reduced because BHT 
precipitated 1n the binding reaction mixture at higher concentrations. BHT Is 
an ant1-ox1dant that helps stabilize BPA 1n solution.
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Table 2
Dilution Assays with Beta-Parlnerlc Acid and Laurie Acid
Attempt # L1p1d
Lipid concentration 
In reaction mixture 
(M)
L1p1d:
monomer
ratio
Highest activity 
as X of 20 pH 
SDS activity In 
dilution assay
Activity of 
exp. as %  
activity 
of control
*
X BPA 5xl0" 6 13:1 24 100
2 LA 3xl0' 2 *4 67:1 80 250
3 BPA 5x10" 5 13:1 27 12 0
4 BPA 5x10"® 13:1 27 —
5 BPA lxlO" 4 26:1 2 2 mmm m
lxlO" 5 2 .6 : 1 25 10 0
lxlO" 6 .26:1 2 2 —
6 LA 3xl0" 4 67:1 64
7 BPA lxlO" 4 13:1 27 m m m
8 BPA lxlO" 4 18:1 34 100
9 BPA
1oX 18:1 36 50
2. Anthroyloxydodecanolc acid
The covalent binding reaction and subsequent dilution assay were tried
many times at very different 1 1 p1d:monomer ratios, from below 1 : 1  up to 
40:1. The best ratio demonstrating covalent binding was 2:1 when the monomer
concentration In the reaction vessel was near 5x10"® M. The results of the 
dilution assay tried at low to middle 1 1 p1d:monomer ratios Is shown In figure 
6A. The dilution assays at higher 11p1d:monomer ratios 1s shown In figure 6B.
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3. Pyrenedodecanolc acid
The dilution assay was tried twice with pyrenedodecanolc acid. The 
results are given In the following table:
Lipid Lipid: Highest activity as
Activity of 
experimental
concentration monomer %  20 nM SDS activity as X activity of
Attempt # . X M L  _ ratio 1 n dilution assay control
1 2.5 x 10' 3 690:1 31 115
2 1 . 0  x 1 0 " 3 344:1 18 10 0
Thus, the results do not support that PDA was covalently bound to the enzyme.
D. Properties of Anthroyloxydodecanolc Acid
1. CMC of ADA
The CMC of ADA and 1 auric acid were determined by measuring the 
concentration of lipid at which light scattering detected at 660 nm becomes 
apparent. The results are:
Lipid Solvent CMC
ADA assay buffer with 20X glycerol 8xl0" 5 M
ADA water 2x10" 4 M
laurlc a d d assay buffer with 20X glycerol 3xl0* 5 M
ft
As expected, micelles formed at a lower concentration for ADA than for laurlc 
acid, because of the anthracene moiety on the former lipid. The light 
scattering with concentration of Upld 1s shown In figure 7A.
2. Light Sensitivity
Molecular Probes, the manufacturer of ADA, reports that ADA 1s light 
sensitive and should be stored in the dark. Also, the Merck Index (1976) 
reports that anthracene exposed to light dimerizes. ADA consists of 
anthracene covalent bound to the non-carboxyl end of laurlc add. So the 
light, sensitivity of ADA was tested. The decline In absorbance at 367 nm over 
time of a 3.0 x 10"® ADA 1n 100 mM NaPO^ 20X glycerol, pH 6.0 buffer 
demonstrates the light sensitivity of ADA. This Is shown In figure 7B. The 
experiment was carried out at room temperature, and a 60 watt Incandescent 
light source was constantly located 50 cm from the sample.
E. Attempts to Reoxidize Reduced, Lipid Bound Pyruvate 0x1da 
1. Dialysis
The fall of specific activity with time of dialysis for a sample of ADA 
covalently bound to pyruvate oxidase and the carbodUmlde control Is shown 1n 
figure 8B. The protein was measured by the Bio-Rad microassay. The large 
error bars are caused by uncertainty in protein concentrations. The spectra 
of the two samples after the first day of dialysis Is shown In figure 9. The 
spectra of the samples after four days of dialysis are noi much different; from 
the spectra after the first day of dialysis. The >p- hal shape |s similar to 
reduced enzyme. However, the absorbance of the solution Is many times larger 
than would be expected with a pyruvate oxidase concentration of 0 .3 mg/ml.
22
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2. ulthlonlte Reduction and Reoxidation with Og 
It seems as 1f I w?s able to reduce pyruvate oxidase In a covalent 
binding reaction mixture that didn't Include AOA or carbodllmlde. The control 
required 50 pi of 2 x Na dithlonlte to change the spectral curve, to one
which suggested reduction. The enzyme concentration was .07 mg/ml. A cloudy 
solution containing white precipitate formed, confusing the spectral data.
The precipitate could not be removed by centrifuging at 14,000 g for 20 
minutes.
3. Chelation of Hn^+
First It was established that ADA can be covalently bound to pyruvate 
oxidase 1n hepes buffer. Upon dilution, the activity of the experimental 
sample (containing carbodllmlde) was 2.5 times as large as the control 
(lacking carbodllmlde). After the solutions were Incubated for an hour, EDTA 
was added. This did not seem to oxidize the sample with covalently bound 
ADA. The sample contained much white precipitate. In another run, EDTA was 
added only six minutes after the addition of carbodllmlde. This seems to have 
reoxidized the sample, as seen by the spectra In figure 10. An unexpllcable 
large peak was found 1n the 370-390 nm range. A slight yellowish coloring 
Indicative of oxidized FAD was observed several minutes after the addition of 
EDTA. The sample was without any cloudiness, unlike the sample with lipid 
covalently bound to reduced pyruvate oxidase. Unfortunately, the EDTA 
treatment seems to have reduced the activity of the enzyme. The protein 
determination Is based on ovalbumin standards of the Bio-Rad assay:
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Sample
with EDTA treatment
Specific activity  
(mwole C0y"Hn~Vr*ova1btm1n)
without EDTA treatment
6.15
18.5
F. Spectral Studies with Anthroyloxydodecanolc Acid
The absorbance, excitation, and emission spectra of ADA were recorded In 
109 nM NaPO^ 20% glycerol, pH 6.0 buffer. The spectra are shown In figures 
11, 12 and 13. In all spectra the effects of the blank are accounted for by 
the position of the baseline.
Udenfrlend and co>workers have shown that the fluorescent probe 
fluorescamlne Is a nonfluorescent molecule that forms highly fluoresecent 
primary amines upon covalent binding (16). Others have shown that «- 
parlnarlc acid Increases In fluorescence Intensity 40 fold upon binding to 
bovine serum albumin (17). Looking for similar enhancement effects upon 
binding, the fluorescence Intensity of ADA In solution, noricovalently and 
covalently bound to pyruvate oxidase were measured. The concentration of ADA 
was the same 1n all three samples. The results are shown In figures 14A and 
14B, The ADA;monomer ratio was 2:1. The experimental sample contained 
covalently bound ADA while the control contained noncovalently bound ADA. The 
experimental sample fluoresced more than the control, and both fluoresced lets 
than ADA free In solution. The fluorescent peak of ADA free In assay buffer 
solution was actually 20% higher than shown. To fit the peak on the graph 
paper, I needed to decrease the fine sensitivity switch on the chart recorder 
amplifier. The emission peaks of the three samples In assay buffer occurred 
at a wavelength 15 nm lower than the emission peak of ADA 1n NaP04 buffer.
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The three samples emitted maximally at 455 nm while the maximal emission of 
AOA In NaP04 buffer occurred at 470 nm.
The last fluorescence experiment attempted to determine whether energy 
transfer can be qualitatively observed. A reduced sample of ADA covalently 
bound enzyme was treated with EDTA to reoxidize pyruvate oxidase while another 
sample was treated with a water blank to keep the enzyme reduced. The 
ADA:monomer ratio was 2:1. The spectra of the samples are shown In figure 
15. The unusually high fluorescence of the blank lacking ADA and EDTA was 
probably caused by probe contamination. The sample with EDTA turned a 
yellowish color upon EDTA treatment while the two controls were colorless.
The EDTA treated sample was clear as water In the fluorescence cuvette, while 
the reduced sample was cloudy 1n the fluorescence cuvette.
G. Attempts to Separate Covalently Bound and Unbound Probe
1. Ammonium sulfate precipitation
The following chart summarizes the results. The protein was determined 
by measurements of absorbance at 438 nm or 280 nm. The resuspended pellets 
containing the enzyme were cloudy white, suggesting that the enzyme was ,»t 
least partially denatured.
Total activity (pinole CO^ m 1 rf*) Total protrm (m
Sample Exp. Control I*JL Control
Original 31.7 2 2 . 6 .58 .58
Final resuspension 7.4 3.2 3.2(1.5) 2.(1 (.99
The values 1n parentheses for the total protein determination are calculated 
from Aogn.
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2. Dialysis
The first experiment Involved dialyzing a sample containing the reaction 
mixture used to covalently bind ADA and observing the fluorescence after two 
days of dialysis. Both the experimental and control samples showed a 90% loss 
In total activity after 24 hours of dialysis. Samples taken after 24 and 48 
hours showed an emission peak at 461 nm. There was little or no difference 
observed between the emission peak of the experimental and control samples.
The second experiment tested the ability of ADA to leave the dialysis 
tubing. The slow mobility of ADA as measured by the loss In Ajgy of the 
dlalysate 1s shown 1n figure 8A.
The third experiment was attempted to reoxidize 11p1d bound pyruvate 
oxidase. The results are given In chapter I U  E, section 1.
3. Ultraflltratlon
The method was tried four times. Only once did I not get a substantial 
loss In total activity of both experimental and control samples. The protein 
concentrations were determined by absorbance at 438 nm. The spectra of the 
samples were measured after ultraflltratlon. A gradually upward rising slope 
from 500 to 350 nm, as exemplified by the spectra of attempt #2, was typically 
observed. The spectra of attempt #2 are shown In figure 16. Such a spectral 
shape Is compatible with reduced enzyme, but the absorbance was much too high 
for the maximal amount of enzyme present. Occasionally a yellow coloration of 
the ultraflltratlon membrane was observed after concentrating. The results of 
the four attempts are:
-V
 v
37
Total activity Total protein Total times
(mnole C0j>/m1n) (mg)__ diluted and concentrated
Attempt I Control Exp Control
1 before ultrafll. 92.4 47.3 1.28 1.28 8
after ultrafll. 50.1 23.4 3.9 1.64
2 before 25.4 11.7 .58 .58 125
after 5.2 1.26 1.5 .82
3 before 18.3 .32 1 0
after 2 . 0 .28
4 before 13.6 1 1 . 0 .26 .26 5
after . 1 0 . 0 .16 .085
4. Ion-retardation resin
The elution profile of a sample of ADA In 100 mM NaPC^, 20X glycerol, pH 
6.0 buffer shows that most of the ADA stuck to the column until the high salt 
elution was begun. This Is shown In figure 17A. The elution profile of 
pyruvate oxidase with covalently bound ADA shows a peak soon after the low 
salt elution was begun and another peak after the high salt elution. The 
elution profile of the first attempt with this column Is shown In figure 
17B. The activity of the enzyme covalently bound to ADA eluting In the first 
peak of the low salt elution was determined, as was the protein (by A4 3 8 ) 
concentration:
ft. '
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Activity Protein
(umole COg/roln) —OmL
Attempt Exp Control Exp Control
1. Sample loaded 16.4 5.5 .32 .32
Low salt peak 1 . 8 . 1 0 .094 .031
2. Sample loaded 34 .64
Low salt pec!' 1.7 .58
All the samples exhibited a peak of A4 3 3 In the third fraction of the low 
salt elution.
5. Extraction with Organic Solvents
The loss 1n the specific activity with extracting ADA covalently bound 
enzyme samples with chloroform and heptane Is shown In figure 18A. The 
protein was determined by the B1o-Rad microassay. In all the sample a white 
precipitate was noticed, especially after the mixing became more vigorous.
The extraction of the ADA Into chloroform 1s shown 1n figure 18B. The extent 
of extraction of ADA Into heptane was not graphed because a standard sample of 
ADA In heptane could not be prepared.
6 . Sephadex G-SO column
Reduced pyruvate oxidase 1n assay buffer was loaded on gel filtration 
columns of two sizes: 1 x 10 cm and 1.4 x 24 cm. The elution profiles are
t
shown 1n figure 19 and 20. The peaks after the void volumes correspond to the 
elution of pyruvate oxidase. The peaks occurring later correspond to the 
elution of assay buffer components. The absorbance spectrum of fraction 5
• •mw» ; mmam muni m

......-
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of the smaller column demonstrated an oxidized enzyme. The larger column was 
tried because ADA loaded on the smaller column eluted with a peak at fraction 
six. Thus, the overlap between the elution profiles of enzyme and ADA 1s too 
large for the smaller column. The protein yields were calculated by the Bio- 
Rad assay. The following yields wers obtained from the columns:
Col umn
%  Activity eluted 1n 
peak after void volume p^ak after void volume
%  Protein eluted 1n
Smal I 50. 6 1 .
Large 5.8 6 0 .
44
IV. DISCUSSION
A. Purification of Pyruvate Oxidase
The purification technique worked well with the new CG-5 strain. Up to 
the low Ionic strength precipitation step. I Isolated nearly 70 mg of enzyme. 
Also, John Cronan's laboratory 1s developing a strain containing cloned 
pyruvate oxidase genes. Ttils will Increase the enzyme purification yield 
dramatlca’ly.
B. Probe Activation of Pyruvate Oxidase
Since I could not covalently bind beta-parlnarlc add to pyruvate oxidase 
I searched for other fluorescent probes that activate the enzyme. The 
activation profiles of four probes were tested. The profiles (figures 2 and 
3) show that ADA and BPA activated the enzyme the most and ANS and PDA the 
least. Thus, I chose to work on covalently binding ADA Instead of PDA or ANS 
to the enzyme. Because ADA contains a bulky anthracene group at the non-' 
carboxy end of dodecanolc acid, I measured the effect of the anthracene moiety 
In activating the enzyme. Figure 3A shows that anthrance activated the enzyme 
only at high concentrations (1x10"^ M). Since I typically used ADA 
concentrations around 10“  ^M, I did not expect the enzyme to be activated much 
by the anthracene moiety of ADA.
The effects of OMSO on unactivated and lipid activated enzyme suggest 
DMSO's mode of action on the enzyme. DMSO's activation of unactivated enzyme 
and Inactivation of Upld activated enzyme suggests that DMSO competes with 
the 11p1ds for the enzyme's activation sites. Since DMSO does not activate 
the enzyme as much as the lipid does, the solvent seems to Inactivate the SDS 
activated enzyme. The results also demonstrate that <t 1s not correct to 
subtract the activation of the enzyme due to the DMSO control from the
activation of a lipid to obtain the solvent-corrected activation of the 
11p1d. The final concentration of DMSO 1n the activation assays was 5% (v/v). 
Hence, DMSO reduced the 11p1d activation of the enzyme by only 5% 1n the 
activity assays for the lipids (figure 4B).
by
C. Covalent Binding of Lipids to Pyruvate Oxidase 
The covalent binding reaction of a lipid to pyruvate oxidase was mediated 
carbodllmlde:
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The dilation assay proves covalent binding between a fatty acid and the 
enzyme 1 f the activity of the experimental sample Increases with time while 
the activity of the control without carbodllmlde remains at a lower activity 
and constant with time. This happens because diluting the samples will push 
the fatty acid binding equation towards the unbound state:
Enzyme + fatty acid t  Enzyme-fatty acid complex
Dilution favors
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The covalently bound fatty acid will not dissociate upon dilution while the 
noncovalently bound fatty a d d  will dissociate upon dilution, The association 
state of the fatty acid-enzyme complex can be determined by the enzyme's 
activity.
The first fluorescent lipid I tried to covalently bind to pyruvate 
oxidase was beta-parlnarlc acid. I believe the results show that BPA was not 
covalently bound to the enzyme 1n these experiments. The strongest evidence 
for the lack of covalent binding 1 s the small or no difference between the 
activity of the sample containing carbodllmlde and the sample without 
carbodllmlde 1n the dilution assay. Also, the poor activation of the 
experimental sample as X of the 20 pM 3DS activity supports the conclusion 
that covalent binding did not occur. With ADA and 1 auric add successful 
covalent binding, as demonstrated by the dilution assay, resulted In an 
activity of 50% and up of the 20 pM SOS activity. The average activation of 
the experiments with beta-par1nar1c add resulted In only 30% activity of the 
20 pM SDS activity.
I'm not sure why BPA lid not covalently bind to the enzyme. It seems 
unlikely that BPA from two batches or pyruvate oxidase from two preparations 
were bad. I also tested and verified the purity of BPA by absorbance In 
solution. To test the reagents and my technique, I twice tried and succeeded 
In covalently binding laurlc add to the enzyme. Also, care was taken to 
deaerate all solutions coming Into contact with BPA by argon bubbling.
Unlike with beta-parlnarlc add, I have covalently bound anthroyloxy- 
dodecanolc add to the enzyme. The optimal Hp1d:monomer ratio was 2:1 for a 
5xl0~” M monomer concentration. The ratio Is optimal because covalent binding 
was well demonstrated by the dilution assay and the low 1 1 pi dimonomer ratio
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would make removing unbound ADA an easier task than If a higher ratio were 
used. The removal of unbound ADA or nonspeclflcally and noncovalently bound 
ADA Is necessary for accurate energy transfer experiments using ADA.
Figure 6B shows that maximal activation by covalent binding occurred at a 
5:1 11p1d:monomer ratio. Higher ratios, up to 40:1, did not change the 
activation significantly. The dilution assays with ADA exhibited the strange 
behavior that at llpldsmonomer ratios of 5:1 or greater, both the experimental 
and control samples would show similar Increases In activation with time. The 
Increase 1n activation with time to an activation of 55% of the 20 SDS 
activity suggests that the enzyme associated with the I1 p1d In such a way as 
to make the dilution assay ineffective. The critical micelle concentration of 
ADA suggests that this was the case. The CMC was determined to be 8x10"^ M 
while the concentration of the lipid 1n the samples exhibiting the strange 
dilution assay behavior began at 5xl0‘ 5 M. It seems probable that the enzyme 
associated with the ADA micelles so that the dilution of the micelle-enzyme 
complex did not dissociate the complex.
The last fluorescent lipid ! tried covalently binding to pyruvate oxidase 
was pyrenedodecanolc acid. From the lack of a difference In the time 
dependent activation profiles of the experimental and control 1n the dilution 
assay and the low activation of the samples In the dilution assay, It does not 
appear as PDA was covalently bound to the enzyme. However, since the covalent, 
binding reaction was run at very high llpldsmonomer ratios, problems with 
micelles may have occurred, as with ADA. I did not attempt to work out the 
covalent binding reaction with PDA because ADA gave much better activation In 
the dilution assay.
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D. Attempts to Reoxidize Reduced, Lipid Bound Pyruvate Oxidase 
Several experiments were tried to switch pyruvate oxidase to the oxidized 
state after covalently binding ADA. Oxidized pyruvate oxidase does not 
aggregate whereas reduced enzyme aggregates. It Is not known whether 
oxidized, lipid covalently bound pyruvate oxidase aggregates like the 
substrate reduced enzyme or forms clear solutions like the native, oxidized 
enzyme. Manipulations of the lipid covalently bound enzyme may be easier If 
the enzyme could be oxidized than If It were left 1n the reduced state. (The 
covalent binding reaction reduces pyruvate oxidase.) Also, energy transfer 
experiments must be conducted with a sample of the enzyme 1 n the oxidized 
state. The three techniques that attempted to reoxidize the lipid covalently 
bound enzyme were:
1. Dialysis
Theoretically, the substrate pyruvate ard the cofactor can be dialyzed 
out of the dlalysate resulting In the reoxidation of the enzyme. Also, 
l<3Fe(CN)g added to the dialysis buffer should help reoxidize the enzyme. 
Dialysis was found not to be a good method to reoxidize the enzyme because of 
the Immediate 2.5 fold loss In specific activity of the experimental sample. 
Precise energy transfer experiments cannot be made with a substantial amount 
of ADA covalently bound enzyme denatured. The spectra of the samples were 
Inconclusive since the gradually upward sloping curve suggestive of reduced 
enzyme absorbed far too much for the known amount of enzyme 1 n the solution. 
The large absorbance was probably caused by the cloudiness of the dlalysate 
samples.
'Ip
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2. D1th1on1te Reduction and Reoxidation with Og
I found this a clumsy method to try to develop. Since the following, 
more promising, method was suggested by M. Recny before further work on this 
method, I stopped working on It.
3. Chelation of Mn2+
Mary Flannery has shown that chelating the divalent cation 1n a sample 
containing reduced pyruvate oxidase results 1 n the Inactivation of the enzyme 
upon mild proteolysis (18). Presumably the removal of the cation causes the 
enzyme to revert to Its native, oxidized state that Is Inactivated upon mild 
proteolysis. The reduced form of pyruvate oxidase 1s activated upon mild 
proteolysis. As judged from the absorbance spectrum, the reduced, ADA 
covalently bound enzyme seems to have been reoxidized upon EOTA chelation. 
Unfortunately, there 1s a 6 6% loss In specific activity caused by this 
treatment. This technique may be further developed. The EDTA treated 
solution looked as a very promising solution to manipulate because 1t was 
clear as water. This Is contrasted to the 11p1d covalently bound, reduced 
enzyme sample which was cloudy and contained small white precipitates.
E. Spectral Studies with Anthroylo^ydodecanolc Acid
The similarity between the absorbance spectrum of ADA and fluorescence 
excitation spectrum were seen as expected. ADA Is a good fluorescent probe to 
use In energy transfer experiments with the FAD cofactor. The overlap between 
the fluorescent emission of ADA and absorbance of FAD Is large. Also, 
pyruvate oxidase fluoresces maximally at 340 nm while being excited maximally 
at 290 nm (19). Thus, there Is no significant Interference between the
fluorescence of ADA and pyruvate oxidase. ADA did not show an Increase In 
fluorescence upon binding covalently or noncovalently to pyruvate oxidase. If 
the probe Increased 1n fluorescence Intensity 40 fold as c1s-par1nar1c acid 
does upon binding to bovine serum albumin, the separation of covalently bound 
ADA and unbound ADA would not be necessary for accurate energy transfer 
experiments. But this was not found with ADA.
The last fluorescence experiment attempted Involved looking for 
qualitative energy transfer between ADA and FAD. Positive results would have 
demonstrated qualitative energy transfer only, because the ADA:monomer ratio 
was 2:1, which Is too high for the quantitation of energy transfer. The 
experiment Involved comparing the fluorescence emission spectra of EDTA 
treated and untreated samples containing reduced, ADA covalently bound 
enzyme. If energy transfer occurred, the EDTA treated (oxidized) sample would 
fluoresce less than the untreated (reduced) sample because of the Increased 
spectral overlap Integral for the oxidized sample versus the reduced sample.
No significant difference between the emission spectra of the two samples were 
observed. This may be caused by the confusion of the results or by the lack 
of energy transfer. The results could have been confused by too great a ratio 
of unbound to bound ADA or by the cloudiness of the EDTA untreated sample (the 
EDTA treated sample was clear). The lack of energy transfer could be due to 
too great a distance between ADA and FAD or, more likely, the loss of enzyme 
conformation caused by EDTA treatment.
F. Attempts to Separate Covalently Bound and Unbound Probe
To quantitatively measure energy transfer, the ADA that Is not covalently 
attached to the enzyme must be removed from the solution. Six methods have 
been tried to accomplish this:
50
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1. Ammonium sulfate precipitation
This technique should precipitate the ADA covalently bound pyruvate 
oxidase while the excess lipid remains 1n solution. It 1s a plausible 
technique because it is used successfully with native enzyme 1n the 
purification procedure. The results showed a drastic loss 1n total activity 
for both the experimental and control samples. I could not calculate the 
change 1n specific activity because the protein determinations by absorbance 
at 438 and ^80 nm were not reliable. The unreliability 1s easily recognized by 
noticing that the total protein determined rose significantly. The correct 
way to have measured the protein values would have been by a method as the 
Bio-Rad, Lowiy, nr Biuret protein assay In these assays, the protein 
determinations are not confused by cloudiness In the samples assayed.
without Information on the specific activities of the samples before and 
after the method, the effectiveness of the method cannot be absolutely 
determined. A loss 1n total activity, as I found In both samples, may be 
caused by the loss of enzyme or the loss of lipid from the solution. It may 
have happened that the experimental sample lost total activity because of a 
loss In the total enzyme while the control sample lost activity because of 
separation of lipid from the sample. Such a case would make the ammonium 
sulfate precipitation technique a possible way to separate bound from unbound 
ADA.
Even 1n light of the uncertainty, however, this technique seems not to be 
a promising technique to separate bound and unbound ADA. First, there 1s a 
75% loss 1n the total activity of the experimental sample that must be due to 
the loss of enzyme, because the 1 1 p1d was covalently bound to the enzyme. 
Second, white precipitate was observed In the resuspended samples, Indicating
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possibly the denaturatlon of enzyme. Third, G. Lelsman has substantiated that 
aiHmonluR sulfate precipitation of 1 auric acid covalently bound enzyme 
Irreversibly denatures the enzyme (20). So 1n view of all the information 
available, 1 do not see this technique as promising.
2. Dialysis
Three experiments were tried to test the feasibility of dialyzing out 
unbound ADA from a dialysis mixture containing covalently bound ADA. The 
first Involved measuring the fluorescent emission of the dlalysate. 
Theoretically, the dlalysate with unbound ADA will fluoresce less than the 
dlalysate with covalently bound ADA because the unbound ADA can leave the 
dialysis bag while the bound ADA cannot. The results showed a 90% loss 1n 
total cxtlvlty of both the experimental and control samples and little 
difference between the fluorescence of the two samples. When the experiment 
was suggested to me I had not optimized the 1 1 p1d:monomer ratio for the 
dilution assay and did not realize that observing the fluorescence of the two 
samples 1s not a good way to show covalent binding has occurred. The problem 
1s that the 11p1d:monomer ratio was 38:1. Thus, If the experiment worked or 
not, little or no difference In the fluorescence emission spectra would be 
expected.
The second experiment Involved measuring the mobility of ADA through the 
dialysis bag. Since only half of the ADA moved out of the dialysis tubing 
after fifty hours of dialysis, the method Is not a good way to separate 
unbound from covalently bound ADA.
The third experiment was undertaken to see If dialysis reoxidizes 11pld 
covalently bound ADA. The large loss of specific activity of both the
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experimental and control samples shown In figure 8B further demonstrate the 
unvlablllty of dialysis to separate bound and unbound ADA.
3. Ultraflltratlon
Theoretically, the unbound ADA should move through the ultraflltratlon 
manbrane while the covalently bound ADA should not because the enzyme cannot 
pass through the membrane. Before the technique was tried with covalently 
bound ADA, experiments showed that ADA did not pass through the membrane, but 
stuck to it.
From the results with covalently bound A?A, the absolute effectiveness of 
the ultraflltratlon technique cannot be determined. The problem 1s that I 
used absorbance at 438 nm to determine the protein concentration. This Is an 
unreliable method to use with any solution but pure, oxidized enzyme 
solutions. When the results are combined with other Information, the method 
does not seem to be the optimal way to separate bound and unbound ADA.
Stevens and Gennls have observed that substrate reduced enzyme at 
concentrations of greater than 0.3 mg/ml aggregated and precipitated (21). I 
have observed a loss of 50 to 100% of total activity of the experimental 
samples using the ultraflltratlon method. The use of the ultraflltratlon to 
concentrate the native, oxidized enzyme In the purification procedure often 
results In a loss of 40% of the total activity. Thus, the enzyme, 
particularly the lipid bound, reduced form, appears to be too sticky for the 
ultraflltratlon technique to be very successful. Additionally, the confusing 
spectra of the ultraflltrated samples are probably caused by the cloudiness of 
the samples. Accurate fluorescence measurements cannot be made with cloudy 
samples.
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4. Ion-retardation resin
Kapp and Vinogradov have devised a quick method to remove SDS from 
proteins (2 2). They showed that loading a sample with a 400 molar excess of 
SDS over ovalbumin onto an 1 on-retardation AG11A8 column resulted 1n the 
elution of a 1:0.6 molar ratio of SOS to ovalbumin. The lipid stuck to the 
column and the protein eluted under low salt elutions. I have found that ADA 
sticks to the column, but I could not quantitate the protein yield of pyruvate 
oxidase covalently bound to ADA. The protein concentration of the elements 
was measured by A4 3g ( a technique that Is not accurate with enzyme not known 
to be pure and oxidized. However, this technique to remove unbound ADA from 
covalently bound ADA does not seem promising. The activity of the lipid 
covalently bound enzyme eluting 1 n the peak of the low salt wash was only 
5-10 %  of what was loaded. Some enzyme eluted after the high salt wash, but 
that enzyme 1s useless since ADA was shown to elute after the high salt wash.
5. Extraction with Organic Solvents.
The large loss 1n specific activity of the samples with extraction 
Indicates that extraction of ADA with chloroform and heptane 1 s not a good 
technique to separate covalently bound and unbound ADA. Significant amounts 
of ADA were extracted Into the chloroform phase only after a loss of at least 
50X of the specific activity.
6 . Sephadex 6-50 column
The results of the column runs were encouraging. Substrate reduced 
enzyme was oxidized and separated from the substrate and cofactors by running 
the enzyme through a 10 cm column. The activity and protein yields were
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high. A 24 cm column was prepared because ADA eluted too closely to the 
enzyme In a control run. Assay buffer reduced enzyme eluted through the 
larger column Inactivated. This was not expected, since the smaller column 
worked 1n eluting active enzyme. Although the Initial results here are 
encouraging, 1t should be noted that others have encountered technical 
problems with eluting reducing pyruvate oxidase from Sephadex columns.
Stevens and Gennls reported that substrate reduced enzyme will not elute from 
Sephadex, Sepharose, Bio-Gel, and Ultrogel gel filtration media (21). Also 
John White attempted to separate unbound 1 auric acid from covalently bound 
laurlc acid using a Sephadex G-10 column. H1$ results wavered. He finally 
seemed to think that the enzyme stuck to the column.
G. Theory of Energy Transfer Applied to Pyruvate Oxidase 
Although I have not attempted quantitative energy transfer experiments, I 
think It would be helpful to outline the theory as applied to this project.
The efficiency of energy transfer can be measured by three methods:
a) From the change In tne excited state lifetime of the energy 
donor with and without the presence of the energy acceptor
b) From the change In the quantum yield (or relative fluorescent 
Intensity) of the energy donor with and without the presence 
of the energy acceptor
c) From the excitation spectrum of the energy acceptor.
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of energy transfer, E 3 - - £ ■ — mj
r +RQ
R0 ■ (JKzQ0n“4) x 9.7 x 103 A 
,) -- spectral overlap between the absorbance
spectrum of the energy acceptor and the 
emission spectrum of the energy donor 
KZ = orientation factor
Q = quantum yield of the donor in the absence 
of the acceptor
n * Index of refraction (11).
In this system, the fluorescent Upld, ADA, would be the energy donor and 
the FAD cofactor would be the energy acceptor. With the FAD cofactor as the 
energy acceptor, energy transfer can only be measured by a) and b), since FAD 
does not fluoresce 1n the enzyme. However, 1f FMN or Riboflavin could be 
substituted for FAD with pyruvate oxidase maintaining activity, fluorescence 
of the flavin group may be observed since the quenching adenine moiety of FAD 
would not be present. This would enable all three methods to be used for 
energy transfer experiments.
The spectral overlap constant, J, should be large with ADA and FAD. ADA 
emits maximally at 455 nm 1n assay buffer while FAD absorbs maximally at 
438 nm. Q0 must be determined by first covalently binding ADA to the enzyme 
and subsequently removing the FAD cofactor, perhaps by a procedure similar to 
one developed to remove FAD from native enzyme (12). The orientation factor 
Introduces the largest error In energy transfer experiments. The factor can 
be determined by the emission anisotropy of the donor. Stryer claims, for a
-6
The efficiency
where
and
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typical value of emission anisotropy, the error Introduced 1n measuring a 
distance of 40 A between chromophore centers 1s 20% (11). Last, Koland and 
Gennls have applied energy transfer methods to determine the distance between 
FAD and the TPP binding site 1n pyruvate oxide. Because of difficulties In 
determining the orientation factor and Q0 , they could only establish an upper 
limit of 20 A as the distance between the two sites (23).
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V. CONCLUSION
The purpose of this project mss to determine the distance between the 
fatty acid high affinity binding site and the FAD cofactor of pyruvate 
oxidase. Fluorescence energy transfer between a fluorescent fatty acid and 
the FAD cofactor was to be utilized. Although I have not been able to run 
quantitative energy transfer experiments, I have worked through several pre>
Ifml nary steps towards the goal.
Pyruvate oxidase was shown to be activated by four fluorescent probes. 
They Include beta-par1nar1c acid, anthroyoxydodecanolc acid, pyrenedodecanolc 
acid, and anlllnonophthalenesulfonlc acid. The covalent binding reaction and 
subsequent dilution assay demonstrating covalent binding was worked out for 
ADA. The covalent binding reaction could not be worked out with BPA. I did 
not attempt to work 1t out with PDA or ANS because ADA activated the enzyme 
more than PDA or ANS.
ADA 1s a good probe for energy transfer studies with FAD. The spectral 
overlap between ADA and FAD Is large. The dilution assay worked optimally 
with a 2:1 ADA:monomer ratio. This Is advantageous because only a low amount 
of unbound ADA need be removed from the covalent binding reaction mixture to 
perform accurate energy transfer experiments. Also, ADA at such a low 
concentration does not form a cloudy solution, which could affect fluorescence 
measurements. ADA has the advantage over BPA that solutions containing ADA 
need not be deaerated as solutions containing BPA do.
Three methods were tried to reoxidize ADA covalently bound enzyme. 
Dialysis and reduction by dltMonlte were found Ineffective or clumsy. 
Chelation of Mnz* was found to be a promising method. Treatment by EDTA 
seemed to have reoxidized the enzyme but also caused some Inactivation. The
59
EDTA treated sample was clear, unlike the untreated sample containing reduced, 
ADA covalently bound enzyme.
Six methods to separate covalently bound ADA from unbound ADA were 
tried. Precipitation by ammonium sulfate, ultraflltratlon, dialysis, 
chromatography by 1 on-retardation resin, and extraction with chloroform and 
heptane were either demonstrated Ineffective or shown not to be promising. 
Chromatography by G-50 Sephadex gave contradictory, but promising results. 
Separation of bound and unbound ADA was shown to be a necessary step for 
energy transfer experiments, since ADA covalently bound to the enzyme did not 
Increase In fluorescence Intensity over free ADA. Finally, the general scheme 
of energy transfer applied to pyruvate oxidase was worked out.
60
VI. REFERENCES
1. Hager, L.P. (1957) J. Biol. Chem. 229. 251-263
2. Williams, F.R. and Hager, L.P. (1966) Arch. Blochem. and Blophvs. 116.
168-i 76 -----------^
3. Cunningham, C.C. and Hager, L.P. (1975) J. Biol. Chem. 250. 7139-7146
4. Deeb, S.S. and Hager, L.P. (1964) J. Biol. Chem. 239. 1024-1031
5. O'Brien, T.A., Schrock, H.L., Russell, P., Blake, R., and Gennls, R.B. 
(1976) Blochem, Blophys. Acta 452. 13-29
6. Russell, P., Hager, L.P., Gennls, R.B. (1977) <). B1ol. Chem,, 252. 7877- 
7082
7. Blake, R., Hager, L.P., Gennls, R.B. (1978) J. Biol, Chem. 253. 1963-1971
8. Schrock, H.L., Gennls, R.B. (1977) J. Biol. Chem. 252. 5990-5995
9. Russell, P., Schrock, H., Gennls, R.B. (1977) J. B1o1. Chem., 252. 7883- 
7887
10. Forster, T. (1948) Ann. Phvslk. 2. 55-75
11. Stryer, L. (1978) Ann. Rev. Blochem. 47. 819-46
12. Recny, M.A., and Hager, L.P. (1982) J. B1o1. Chem. 257. 12878-12886
13. Kalckar, H.M. (1947) J . Biol. Chem. 167. 461
14. Bradford, M.M. (1976) Anal. Blochem. 72, 248-254
15. Fairley, R. (1981) B.S. thesis, University of Illinois at Urbana- 
Champalgn
16. Udenfrlend, S., et aU. (1972) Science 178, 871-72.
17. Sklar, L.A., Hudson, B.S., Slmml, R.D. (1977) Biochemistry 16 5100-5108
18. Flannery, M. (1981) M.S. thesis, University of Illinois at Urbana- 
Champalgn
19. O'Brien, T.A., Shelton, E., Mather, M. Gennls, R.B. (1982) Bloch.
Blophys. Acta 705. 321-329
20. G. Lelsman, personal communication
21. Stevens, D.J., and Gennls, R.B. (1979) J. Biol. Chem.
22. Kapp, O.H., and Vinogradov, S.N. (1978) Anal, Blochem
23. Koland, J.G., and Gennis, R.B. (1982) Biochemistry 21
265. 379-383 
_91, 230-235 
, 4438-4442
